RegWardenFDA facility compliance records
Recall

Class II — DePuy Mitek, Inc., a Johnson & Johnson Co.

Recalling firmDEPUY MITEK, A JOHNSON & JOHNSON COMPANY
Registered facilityDePuy Mitek, Inc. (the firm's only registered facility)
ClassificationClass II
StatusTerminated
ReasonAdditional Instructions for Use and Surgical Technique for the Confidence Needle due to reports of breakage with the side fire needles
ProductDepuy Spine Side Fire Needles 11G X 6IN Side-Fire Needle, part of the Confidence Spinal Cement System Product Code 283904611. The Confidence Side Fire Needle is used to place bone cement in an intra-vertebral fashion at a desired location. the cement extrudes fro the needle through a port on the side of the needle.
Quantity530 units
DistributionWorldwide Distribution-USA (nationwide) and the countries of Canada, Austria, China, Croatia, Czech Republic, France, Germany, Greece, Hungary, Italy, Lebanon, Netherlands, New Zealand, Poland, Russian Federation, Singapore, South Africa, Spain, Switzerland, Turkey, UAE, and UK.
Initiated2012-05-04
Classified2012-07-03
Terminated2016-08-04
Recall numberZ-1939-2012
InitiationVoluntary: Firm initiated

Source: U.S. FDA via openFDA (opens in a new tab) (device registration & enforcement). Data as of 2026-10-06. Verify this recall record at FDA → (opens in a new tab)

Cite this record

RegWarden. “Class II recall — DePuy Mitek, Inc., a Johnson & Johnson Co. (Z-1939-2012).” Compiled from U.S. FDA public records (openFDA; FDA Data Dashboard). Data as of 2026-10-06. https://regwarden.com/recall/61874/

Not open yet

Alerts for DEPUY MITEK, A JOHNSON & JOHNSON COMPANY

Watchlist alerts will email you when FDA publishes a new recall, inspection classification, or warning letter for a facility you follow. They aren't open to the public yet — leave your email and we'll tell you when they are.

Planned

Want a one-page facility brief?

A single-page summary of this facility's registration and recall history for diligence. Not selling it yet — register interest and we'll follow up.